Name: Biopharmaceutical Formulations
Brand: Light-Hope Diagnostics, Inc.

Health and Medical

Light-Hope Diagnostics’ Early Cancer Detection Panel is a PCR-based test utilizing liquid biopsy technology to detect a panel of novel small non-coding RNAs indicative of early-stage cancer. This test offers a non-invasive alternative to traditional diagnostic methods, eliminating the need for cold chain management and significantly reducing diagnostic costs. The panel is designed for use in clinical settings and offers a high degree of sensitivity and specificity.

Early Cancer Detection Panel

Science and Engineering

Biotechnology

Light-Hope Diagnostics, Inc.

Utah

Biopharma

Life Science

Light-Hope Diagnostics develops proprietary biopharmaceutical formulations and lyophilization technologies to ensure the long-term stability of our diagnostic reagents at ambient temperatures. This eliminates the need for complex cold chain logistics, making our tests more affordable and accessible globally. These formulations are critical to the performance and shelf-life of our diagnostic panels.

Biopharmaceutical Formulations

Other products/services from Light-Hope Diagnostics, Inc.

Early Cancer Detection Panel

N/A